GHRP-6 vs NAD+: What Is the Difference?
A peptide with a famous discovery story against a coenzyme that predates almost everything else in the catalogue.
In plain English
GHRP-6 is a six-amino-acid molecule from the 1980s that triggers growth hormone release, and which led researchers to the discovery of ghrelin.
NAD+ is a coenzyme — not a peptide — first identified in 1906, present in every living cell and central to the chemistry of energy metabolism.
The difference, without the jargon
Different chemical families, different eras, different purposes. GHRP-6 is a signalling molecule: it acts on a receptor and triggers a hormonal response. NAD+ is working chemistry, consumed directly by the reactions that keep cells running. That is why NAD+ arrives in 500 mg vials while GHRP-6 comes in 10 mg. Their storage vulnerabilities are also unrelated: GHRP-6 must be kept dark because it contains two tryptophan residues and yellows as it degrades, while NAD+ must be kept dry because it absorbs moisture from the air, and away from alkaline conditions, which break it apart quickly. The one habit they share is that neither should be opened straight from cold storage without letting the sealed vial warm first.
Common questions
Is NAD+ a peptide like GHRP-6?
No. GHRP-6 is a peptide, a chain of six amino acids. NAD+ is a coenzyme built from nucleotides, with different chemistry and different handling rules entirely.
Why did GHRP-6 lead to a hormone discovery?
It worked on a receptor nobody had identified. Researchers cloned that receptor in 1996, then searched for the natural molecule meant to activate it. The search ended in 1999 with ghrelin — found because a synthetic compound pointed the way.
What is the biggest storage difference?
GHRP-6 needs darkness because of its tryptophan content. NAD+ needs dryness because it pulls moisture from the air, and neutral or mildly acidic conditions because alkalinity destroys it.
Technical reference below
How they actually differ
Comparing the two: GHRP-6 is synthetic hexapeptide, met-enkephalin analogue and ghrelin-receptor agonist, while NAD+ is dinucleotide coenzyme — not a peptide — different molecular classes with different handling consequences; their leading degradation routes differ (tryptophan photo-oxidation at two independent positions for GHRP-6, alkaline hydrolysis for NAD+), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
GHRP-6 — origin
GHRP-6 was among the first synthetic growth hormone secretagogues, developed from met-enkephalin analogues in the 1980s — years before the ghrelin receptor it acts on was even identified. It is a genuine piece of pharmacological history: the compound was found first and its target second, and that search for the endogenous ligand of its receptor eventually led to the discovery of ghrelin in 1999.
NAD+ — origin
NAD+ is not a peptide at all, and that single fact governs everything about how it is handled. It is a dinucleotide coenzyme — nicotinamide and adenine linked through a pyrophosphate bridge — present in every living cell and central to redox metabolism. It was first identified in 1906 by Arthur Harden as a small heat-stable factor required for yeast fermentation.
GHRP-6 research themes
Acts at GHS-R1a — the receptor whose search for an endogenous ligand led to ghrelin's discovery.
Strong GH-releasing activity in research models, historically the compound's defining property.
Ghrelin-receptor activity links it to appetite pathways in metabolic research models.
A landmark in reverse pharmacology: the synthetic ligand preceded knowledge of both receptor and natural ligand.
NAD+ research themes
Sirtuins consume NAD+ as a co-substrate, which links cellular NAD+ availability directly to their activity.
Its canonical role as the central redox carrier of cellular respiration.
PARP enzymes consume NAD+ during DNA damage response, a heavily studied competing demand.
A major driver of current research interest: measured NAD+ levels fall with age across tissues in animal models.
GHRP-6 handling
- Amber vials or foil wrapping should be treated as required, not optional.
- Reconstitute under reduced lighting where practical.
- Avoid contact with trace metals, which catalyse oxidative degradation of aromatic residues.
NAD+ handling
- Allow the sealed vial to reach room temperature before opening — opening a cold vial of hygroscopic material condenses water directly onto it.
- Keep solutions at or below neutral pH; alkaline conditions destroy NAD+ quickly.
- Prepare fresh solutions where concentration accuracy is important rather than relying on stored stock.
- Protect from light at all stages.
Both third-party tested
Every Popular Peptides batch of GHRP-6 and NAD+ is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
GHRP-6 reference
Related comparisons
GHRP-6 and NAD+ are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.